Abstract: Stability in Urine of Authentic Phenylglyoxylic and Mandelic Acids as Urinary
Styrene (styrene monomer or phenylethylene; CAS No. 100-42-5) is an important material widely used around the world for synthesis of polymers and co-polymers, such as plastics (e.g., polystyrene), synthetic rubbers (e.g., styrene-butadiene rubber), and materials for surface coating. Substantial exposure to styrene vapor may take place especially during the production of fiber-reinforced plastics boats (FRP-boats), typically in small-scale shipbuilding industries 1) . Co-exposure to other solvents such as toluene, ethyl acetate, methyl ethyl ketone and methanol may take place in workplaces where styrene is a major contaminant in the air 2) . Accordingly, biological monitoring to detect styrene exposure has been commonly practiced in occupational health, and phenylglyoxylic acid (PhGA) and mandelic acid (MA) in urine have been recommended as markers of styrene exposure 1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . One of the concerns over the use of PhGA as an exposure marker is possible instability of this acid during storage of urine samples prior to analysis 14) . Although this possibility has been attracting attention since as early as the 1960's 17) and the 1970's 18, 19) , opinions are not yet unanimous and the notice with regard to biological exposure monitoring practice stays at the level of expression of concerns over the instability of PhGA 14) without specific recommendation on how to deal with such potential difficulties. The major problems come from insufficient presentation of scientific evidence with regard to the instability (except for Kivistö et al. 20) ). Some early reports express conclusions (assumedly experiencebased one) with no detailed presentation of supporting evidence 18, 19, 21) although their conclusions were subsequently respected.
The present study was initiated to clarify the conditions under which PhGA and MA (the former in particular) in urine samples may decompose during storage. It is apparently desired that the risk of decomposition be minimized in the practice of styrene biological monitoring in occupational health.
Subjects, Materials and Methods

Donors of urine samples
Sixteen men in total (aged at 30 to 62 yr) with no occupational exposure to organic solvents (including styrene) offered urine samples for the study. The donors provided informed consent and the study design was approved by the Medical Ethics Committee of Kyoto Industrial Health Association.
Preparation of urine samples containing PhGA and MA
PhGA and MA were dissolved separately in re-distilled water at the concentration of 10 g/l, and 3 and 7 portions, respectively, were mixed together to prepare a solution containing 3 g PhGA and 7 g MA/l (to be called the PhGA-MA solution). The procedures were as follows (unless otherwise specified). A 1-ml aliquot of the PhGA-MA solution was placed in five tubes. The solution in each tube was diluted with one urine (or water) sample to a volume of 20 ml, so that the final concentrations in each urine (or water) sample in a tube were 150 mg PhGA and 350 mg MA/l urine (or water). These concentrations were selected after considering the biological exposure limit for styrene 16) of 430 mg (PhGA+MA)/l and the observed predominance of MA in the ratio between PhGA and MA 3) . Each PhGA+MA-spiked urine (or water) sample was divided into fractions of 1 ml/tube. The tubes were then tightly sealed for storage.
Storage of the urine samples
The tubes containing PhGA+MA samples were taken to a freezer (at -20°C) immediately after termination of storage at 4 or 25°C for 0 to 14 days. The storage at 25°C was under artificial light at 400 lux during work time (9:00 to 17:00) only and in darkness (i.e., windows being shaded with curtains) otherwise (and never exposed to direct sunlight). The storage at 4°C was in a refrigerator and in the dark. A series of frozen samples (of different duration of storage at 4 or 25°C) were thawed at one time to minimize possible batch-to-batch difference in analysis. The storage duration of up 14 days was selected taking into account the fact that urine samples for biological monitoring are seldom left in a refrigerator for more than a week.
Instrumental analysis for phenylglyoxylic acid and mandelic acid
A 50-µl portion of the each thawed sample was diluted with 2 ml redistilled water. After thorough mixing, about 0.5 ml portions of each diluted sample were taken into 3 high-pressure liquid chromatograph (HPLC) vials (vial volume; 1.5 ml) so that each sample was analyzed in duplicate (or in triplicate, if necessary).
Urinalysis was conducted by an HPLC method 22) . The HPLC equipment used was a Hitachi Model L-7100 (Hitachi-Naka, Japan) connected to a UV detector (Hitachi Model L-7400) and an auto-sampler (Hitachi Model L-7200, in which the samples were maintained at 4°C until analysis). The HPLC column employed was 150 mm in length and 4.6 mm in inner diameter, and was packed with Inertsil ODS (diameter of the granules, 5 µm). The mobile phase was a mixture of 25 mM K H 2 P O 4 -7 . 3 m M H 3 P O 4 b u f f e r ( p H 2 . 9 ) : acetonitrile=90:10, and was allowed to flow at a rate of 1.1 ml/min. The column was kept at room temperature (i.e., at about 25°C). For analysis, 10 µl of each sample was introduced to the system, and the effluent was monitored at 202 nm. When PhGA and MA were dissolved in water or five different urine samples (at a final concentration of 20 mg/l for both, or two times the lowest concentration in the calibration curve setting), the coefficient of variation [= arithmetic standard deviation (ASD)/arithmetic mean (AM)] was 2.3 and 3.0% for PhGA and MA in water, respectively, and the coefficient was the same when dissolved in urine (n=5). When the MDL (method detection limit) was calculated as MDL = t (n-1, 0.05) × ASD [t (n-1, 0.05) for one-tail test being 2.132 with n=5] and the LOQ (limit of quantitation) was calculated as LOQ=3 × MDL, the LOQ was 3.3 mg/l for PhGA and 7.0 mg/l for MA. Accordingly, 10.0 mg/l was taken as the LOQ common to PhGA and MA. Typical chromatograms are depicted in Fig. 1 , in which the retention times for PhGA and MA were about 4.2 and 7.7 min, respectively, after injection of a sample. The determination was repeated every 15 min.
Preparation of acid or alkaline urine samples
To prepare acid urine samples, 5 ml of the PhGA-MA solution was mixed with 10 ml of the 500 mM phosphate buffer (KH 2 PO 4 -Na 2 HPO 4 , pH 8.0), and the volume of the mixture was adjusted to 100 ml with a urine sample. The sample was then divided into 5 portions (20 ml each), and the pH of the sample was adjusted to 4.0, 5.0, 6.0, 6.5 or 7.0 by addition of minimum amounts (up to 0.26 ml) of 35% HCl. Alkaline urine samples were prepared with 500 mM ammonium buffer (NH 4 OH-NH 4 Cl, pH 8.7) and 2M NaOH (up to 0.5 ml) in place of the phosphate buffer and HCl, so that the final pH was 7.0, 7.5, 8.0 or 9.0, respectively.
Chemicals
PhGA (purity; >98%) and MA (purity; >99%) were purchased from Wako Pure Chemicals, Osaka, Japan.
Statistical analysis
Determinations were repeated two to three times per sample, and AM was taken as the representative value. The determination was reproducible, with the difference among the duplicate or triplicate samples less than 10% at maximum. As it was not known if PhGA and MA after storage distribute normally, the levels were expressed in terms of AM ± ASD and MED (median), and the significance of possible decrease in PhGA and MA was examined both by parametric paired t-test and nonparametric Wilcoxon test (with and without assumption of normal distribution, respectively).
Results
Calibration for PhGA and MA
A preliminary analysis with authentic PhGA and MA showed that the calibration lines prepared with urine samples from non-exposed subjects had slopes slightly steeper than the slope of the calibration line with water in place of urine, for both PhGA and MA [by +25 ± 2% (+26%) and +19 ± 7% (+19%) as AM ± ASD (MED) for PhGA and MA, respectively]. There was no significant (p>0.05) difference between the two as examined by paired t-test and Wilcoxon test. As the increment of the slope varied slightly subject to urine samples, the calibration was made using the water-based line. This procedure (together with the different background levels for PhGA among the 5 cases) induced a small variation in the initial levels of PhGA and MA ( Table 1) .
Stability of phenylglyoxylic acid and mandelic acid under different storage conditions
Possible decrease of PhGA and MA concentrations in water or urine from five donors (urine samples A, B, C, D and E with pH of 7.0, 7.0, 7.5, 7.0 and 8.5, respectively) was examined after storage at 4°C or at 25°C for 0, 1 (i.e., the next day), 3, 7, 9 and 14 days. In addition, nonspiked samples (water or urine) were analyzed for PhGA and MA after the storage under two conditions (at 4 or 25°C) for 0 and 14 days. The results are summarized in Table 1 , in which the levels in urine samples A to E are expressed in terms of AM ± ASD, and also MED.
Storage for one day (i.e., analysis on the next day of collection) either at 25°C or at 4°C did not reduce PhGA or MA levels. Nevertheless, the decrease in PhGA was evident when stored at 25°C for a longer time. Both AM and MED tended to be decreased on the 7th day of storage, and ASD appeared to be enlarged. On the 14th day, examination by Wilcoxon test (but not by paired t-test) showed a significant decrease (p<0.05) as compared with the initial levels (i.e., the level on the day of storage). When stored at 4°C, PhGA levels in urine appeared to be stable up to 3 days. The levels, however, tended to be decreased when stored for 7 days and longer, although the decay was not statistically significant when examined either by paired t-test or by Wilcoxon test (p>0.05 for both). The AM background level of PhGA (i.e., PhGA in urine without addition) appeared to be reduced during the 14-day storage, being more so at 25°C than at 4°C. The MEDs however remained unchanged, and the difference was statistically insignificant (p>0.05 by Wilcoxon test).
In contrast, the differences in PhGA (145.2 ± 16.4 mg/ l, as AM ± ASD; n=5) between the PhGA-spiked sample and the corresponding background level (or the increment due to the PhGA addition) in samples on the day of the initiation of the storage at 4 or 25°C (i.e., the samples stored at -20°C for 14 days) were essentially the same (p>0.05) with the initial level of PhGA dissolved in water (153.2 ± 16.4 mg/l; n=6). This observation suggests that PhGA in urine was not decreased during the 14-day . Urine sample G in Table 2 , spiked with PhGA (150 mg/l) and MA (350 mg/l) on the 0th day (i.e., the day of preparation); [b] . the same sample on the 4th day at 25°C; [c] . the same sample on the 7th day at 25°C.
storage at -20°C in a freezer. MA levels as expressed by AMs and MEDs did not change throughout the test period, irrespective of storage temperature of 4°C or 25°C. This high stability of MA was in sharp contrast to the storage condition-dependent decrease in PhGA.
Observation of decay in PhGA on an individual basis
The enlargement of ASD values for PhGA especially in the second half of the observation period (Table 1) suggested that further perusal on an individual basis was necessary. Accordingly, the data for each case (i.e., urine samples A to E) were plotted against time to the 14th day of storage at 25°C (Fig. 2A) or 4°C (Fig. 2B) . The observation on the individual basis clearly shows that PhGA levels in two urine samples of C ( in Fig. 2A ) and E ( ) were decreased on the 7th day of storage and later when kept at 25°C, so that the AM values also tended to be decreased (although insignificantly, p>0.05), whereas the three other samples showed less decreases in PhGA levels ( Fig. 2A) . The decreases in these urine samples were less evident when the samples were kept at 4°C (Fig. 2B) . The decrease was, however, more substantial in urine samples C and E than in other samples.
No decrease was observed in MA in all urine samples kept at 4°C or 25°C. Accordingly, no graphic presentation was made for individual cases.
Confirmation of decrease in PhGA, and possible effect of pH on the stability
In order to investigate if three days are the maximum duration of storage with no significant decrease and if pH affects the stability of PhGA, the experiments were repeated with a different batch of urine samples, F to J, with due attention to the pH of the samples. After the samples were spiked with the PhGA -MA solution and the pH of each sample was recorded, they were stored for 0, 4 or 7 days at 4 or 25°C, and the levels of remaining PhGA and MA were examined. Control samples were prepared by use of water in place of urine. The observed changes are summarized in Table 2 .
When kept at 25°C for a week, the decrease in PhGA was substantial (i.e., by 21 to 78%) irrespective of urine samples, in confirmation of the previous findings. Nevertheless, no new unidentified peak was detected in the chromatogram (e.g., urine sample G in Fig. 1 ). When kept at 4°C, no significant decrease (p>0.10) in PhGA was detected on a group basis after storage for up to a week (Table 2 ). Nevertheless, perusal on an individual basis disclosed that the decrease in urine sample F (with pH 6.8, which was highest among the five) was large (i.e., 17% on the 4th day and 23% on the 7th day), whereas urine samples I and J (with the lowest pH of 5.5 and 5.3, respectively) showed essentially no decrease. This observation cannot be taken as conclusive, yet it may suggest the possible effect of pH on the stability of PhGA.
Effect of high pH on the stability of PhGA in urine
To examine quantitatively the possible effect of pH on the stability of PhGA in urine, urine samples were subjected to prepare samples with various pH (pH 4 to pH 9). Each sample was further divided into two portions, one portion to be stored at 25°C, and the other to be kept at 4°C for 0, 4 or 7 days. Six sets of the entire series were prepared with urine samples from six subjects (urine samples K to P, respectively).
The results of the analyses are summarized in Table 3 . When kept at 25°C for 4 days, the decrease in PhGA was as a function of an increase in pH from 4.0 to 6.5 with no further decrease at higher pH. The pH-dependent Table 1 ), urine sample B, urine sample C, urine sample D, and urine sample E. connected with thick lines show the average. connected with thick broken lines indicate the levels of PhGA dissolved in water. The values under urine sample are in percent, taking the 0th day value as 100%.
decrease was more marked when kept for 7 days. Individual differences were also substantial, and PhGA in one urine sample almost disappeared at pH 9.0 (i.e., only 5% remained; the Min column at 25°C for 7 days in Table 3 ). When kept at 4°C, PhGA appeared to stand better. The level tended to be reduced at higher pH (from 4.0 to 8.0), but less remarkably. Thus, the worst recovery case (i.e., the minimum, or Min) was >90% at pH 4.0 even after the 7-day storage, although it was about 50% at pH 7.5, again indicating a substantial difference in stability among urine samples. No significant reduction in MA was detected irrespective of urine samples or storage conditions (data not shown).
Discussion
The present study demonstrates that the PhGA level in urine will stay unchanged for 4 days on a group basis when kept in a refrigerator (i.e., at 4°C; Table 2 ), but will be decreased gradually after storage for a longer period even if kept at this temperature ( Table 1 ). The decrease may start earlier when left at 25°C, and the extent of the decrease may vary subject to urine samples (Table 2) . Although pH was among the influential factors (Table  3) , other unidentified factors may also be involved in the decrease. In contrast, no reduction was observed in MA during the test storage period of 14 days even at 25°C. When kept at -20°C, no significant decrease was observed both in either PhGA or MA during the storage.
Literature survey shows that Huyser and Neckers 17) observed that alkyl esters of PhGA dissolved in ethanol underwent photochemical reduction to corresponding esters of MA, when kept at 30°C in a Pyrex tube and exposed to sunlight for two days. In a separate report, Guillemin and Bauer 18) stated that PhGA cannot be stored in urine without decrease except for kept frozen at -20°C. However, no data were presented on the stability at -20°C or on expected decreases when kept otherwise. In a subsequent report, Guillemin and Bauer 19) described that the decrease in PhGA after 4-h storage at room temperature was about 50% in acidified urine samples and it was 25% in non-acidified urine samples, but further decrease was insignificant upon prolonged storage. Thus, Guillemin and Bauer 23) recommended zinc-mediated conversion of PhGA to MA, prior to transfer to analytical laboratories, to measure total MA (i.e., PhGA+MA) as an exposure marker. Nevertheless, the biological half-life (T 1/2 ) of urinary excretion after termination of styrene exposure is different between PhGA and MA; the T 1/2 is longer for PhGA (i.e., 8.1 11) , 8.8 24) , or 10.5 h 19) ) than for MA (i.e., 2.1 11) , 3.6 24) , or 3.9 h 19) ). Thus, separate monitoring of the two markers is apparently recommended. Rather in contrast to thě conclusion by Guillemin and Bauer 19) , Flek and Sedivec 21) found that PhGA in urine samples remained unchanged for at least 14 days when kept in a refrigerator, and they saw no need to freeze samples at -20°C. In a stability study, Sperlingová et al. 25) pooled urine samples from workers who were exposed to styrene (men and women in combination) and stored the mixed sample at 3-6°C in the darkness. When PhGA (about 140 mg/l) and MA (about 267 mg/l) were measured after 6, 12, 16, 20 and 24 months of storage, no significant reduction was detected not only in MA but in PhGA.
Kivistö et al. 20) investigated the stability of PhGA and MA in urine samples which were offered by styreneexposed workers. The major findings are summarized in Table 4 . In Study 1, MA was quite stable without significant decrease under all storage conditions, either at 6°C or at -18°C. PhGA appeared to be less stable than MA when kept at room temperature for one day, or even at 6°C when kept for a long time, 70 days. In Study 2, the decreases in AM values in PhGA and MA were minimal after storage for 30 days at 6°C, but the ASD values were as large as 26% for PhGA and 16% for MA, suggesting that inter-individual variations in the decreases were substantial.
The results of the present study are in agreement with the previous findings in the sense that PhGA (although not MA) in urine is unstable when kept at 25°C, and will not stand for several days 19, 20) . PhGA will be preserved for 4 days when kept at 4°C (Table 1) , but a decrease may take place after longer storage. Thus, the observation does not support previous reports that no change took place in 14 days or even for a longer time when refrigerated 21, 25) . When kept frozen, both PhGA and MA can stand much better, with essentially no decrease for at least 14 days (Table 1 ) and possibly even for 70 days 20) ( Table 4) .
Another point worthy of noting is that the extent of the decrease in PhGA levels in urine at 25°C as well as at 4°C varies subject to urine samples ( Fig. 2A and Fig.  2B) ; the difference in the extent of the decrease was more evident when kept at 25°C. The present observation on the enlargement of ASD after storage at 25°C for 14 days (Table 1) is on line with the findings by Kivistö et al. 20) ( Table 4) . Reduced stability of PhGA in urine samples at higher pH (Table 3 ) may explain such findings at least in part, but other unidentified factors may be involved.
A point not yet well studied is the potential effect of light on the stability of PhGA during storage. It was previously observed that PhGA may undergo a photochemical reaction 17) . It is dark inside a refrigerator or a freezer, when the door is closed. The storage at room temperature may however be under room light. The possibility of photochemical decomposition apparently deserves further study regarding whether or not the influx of energy as room light contributes to the decrease of PhGA.
From the practical viewpoint, the lessons of the present study in urinalysis for biological monitoring of styrene exposure can be summarized as follows: 1. It is recommended to analyze urine samples on the day of collection, if all possible. 2. Urine samples should be analyzed within 4 days after sample collection even if they are kept refrigerated. 3. If the analysis cannot be completed within a few days, urine samples should be frozen. 4. Additional care may be necessary for urine samples with pH 6.0 or above. As the pH of urine samples is seldom measured in biological monitoring, quick refrigeration (freezing if possible) after sampling irrespective of urine pH is a practical solution. 
